Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Busch

Showing results (111-120 of 504) with videos related to

Pageof 51
Sort By:
Transfusion|December 25, 2003
Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assayJoan D McAuley, Sally Caglioti, Robert C Williams, et al.
American Journal of Epidemiology|January 22, 2008
Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donorsAnne M Guiltinan, Zhanna Kaidarova, Brian Custer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2005
Intermittent low-level viremia in very early primary HIV-1 infectionEberhard W Fiebig, Charles M Heldebrant, Richard I F Smith, et al.
Blood|January 18, 2008
The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patientsRyan M Gill, Tzong-Hae Lee, Garth H Utter, et al.
Transfusion|October 15, 2016
Feasibility of routine ferritin testing for donor management: validation of delayed processing and demonstration of within donor reproducibility over timeMars Stone, Donald Brambilla, Karla Murcia, et al.
Transfusion|May 22, 2003
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screeningSteven H Kleinman, Mary C Kuhns, Deborah S Todd, et al.
AIDS Research and Human Retroviruses|July 13, 2006
The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody responseM Scott Killian, Philip J Norris, Bhupat D Rawal, et al.
Antiviral Research|August 11, 2004
Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infectionDavid M Asmuth, Michael P Busch, Megan E Laycock, et al.
JAMA|May 8, 2003
Effect of a national disaster on blood supply and safety: the September 11 experienceSimone A Glynn, Michael P Busch, George B Schreiber, et al.
Transfusion|September 26, 2003
Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patientsW Lawrence Drew, Sunwen Chou, Beth A Mohr, et al.
Pageof 51

Showing results (111-120 of 504) with videos related to

Sort By:
Pageof 51
Transfusion|December 25, 2003
Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assayJoan D McAuley, Sally Caglioti, Robert C Williams, et al.
American Journal of Epidemiology|January 22, 2008
Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donorsAnne M Guiltinan, Zhanna Kaidarova, Brian Custer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2005
Intermittent low-level viremia in very early primary HIV-1 infectionEberhard W Fiebig, Charles M Heldebrant, Richard I F Smith, et al.
Blood|January 18, 2008
The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patientsRyan M Gill, Tzong-Hae Lee, Garth H Utter, et al.
Transfusion|October 15, 2016
Feasibility of routine ferritin testing for donor management: validation of delayed processing and demonstration of within donor reproducibility over timeMars Stone, Donald Brambilla, Karla Murcia, et al.
Transfusion|May 22, 2003
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screeningSteven H Kleinman, Mary C Kuhns, Deborah S Todd, et al.
AIDS Research and Human Retroviruses|July 13, 2006
The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody responseM Scott Killian, Philip J Norris, Bhupat D Rawal, et al.
Antiviral Research|August 11, 2004
Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infectionDavid M Asmuth, Michael P Busch, Megan E Laycock, et al.
JAMA|May 8, 2003
Effect of a national disaster on blood supply and safety: the September 11 experienceSimone A Glynn, Michael P Busch, George B Schreiber, et al.
Transfusion|September 26, 2003
Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patientsW Lawrence Drew, Sunwen Chou, Beth A Mohr, et al.
Pageof 51